Detalhe da pesquisa
1.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145560
2.
Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Blood
; 141(10): 1194-1208, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044667
3.
Bispecific Antibodies and Autologous Chimeric Antigen Receptor T cell therapies for Treatment of Hematological Malignancies.
Mol Ther
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822527
4.
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.
Lancet Oncol
; 25(4): 488-500, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547893
5.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325065
6.
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis.
Cytotherapy
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506769
7.
Taking T-Cell Oncotherapy Off-the-Shelf.
Trends Immunol
; 42(3): 261-272, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536140
8.
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Mol Ther
; 31(1): 24-34, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36086817
9.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270816
10.
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
Haematologica
; 108(7): 1840-1850, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373249
11.
Targeting glycans for CAR therapy: The advent of sweet CARs.
Mol Ther
; 30(9): 2881-2890, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821636
12.
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy.
Cytotherapy
; 24(3): 282-290, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955406
13.
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.
Mol Ther
; 29(5): 1808-1820, 2021 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571680
14.
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.
Mol Ther
; 28(5): 1251-1262, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145203
15.
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
Blood
; 132(22): 2351-2361, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262660
16.
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.
Mol Ther
; 27(1): 272-280, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391141
17.
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.
Blood
; 130(3): 285-296, 2017 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28539325
18.
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals.
Blood
; 130(25): 2739-2749, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079582
19.
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
Mol Ther
; 26(12): 2727-2737, 2018 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30309819
20.
Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.
Biol Blood Marrow Transplant
; 24(7): 1424-1431, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550628